<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00359918</url>
  </required_header>
  <id_info>
    <org_study_id>Reg.-Nr. 008/2006</org_study_id>
    <nct_id>NCT00359918</nct_id>
  </id_info>
  <brief_title>Randomized Multicenter Trial of Prehospital Initiated Facilitated Percutaneous Coronary Intervention (PCI) Versus Primary PCI in ST-segment-Elevation MI (STEMI)</brief_title>
  <acronym>LIPSIA STEMI</acronym>
  <official_title>Randomized, Controlled Multicenter Trial of Prehospital Initiated Facilitated PCI Versus Primary PCI in Patients With STEMI LIPSIA-STEMI Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prehospital initiated facilitation of primary percutaneous coronary intervention by
      fibrinolysis might be helpful in re-opening the infarct related artery prior to percutaneous
      coronary intervention.

      This studies tests the hypothesis that prehospital initiated facilitated PCI is superior to
      primary percutaneous coronary intervention with respect to infarct size.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with STEMI with symptoms &lt; 3 hours are randomized in the region of Leipzig to either
      prehospital full-dose fibrinolysis (+ASA, Clopidogrel and heparin) with subsequent
      facilitated percutaneous coronary intervention or to primary percutaneous coronary
      intervention (after ASA + heparin + clopidogrel).

      Patients undergo cardiac magnetic resonance for assessment of infarct size early at day 1-4
      after randomization.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infarct size and microvascular obstruction assessed by MRI</measure>
    <time_frame>1-6 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical endpoints (bleeding, death, Re-MI, stroke)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ST-segment resolution</measure>
  </secondary_outcome>
  <enrollment type="Actual">162</enrollment>
  <condition>Myocardial Infarction</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fibrinolysis</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Angina pectoris &lt; 3 hours

          -  ST-elevation myocardial infarction

        Exclusion Criteria:

          -  Active bleeding

          -  Active gastric ulcus

          -  Previous stroke

          -  Uncontrolled hypertension (&gt; 200 mmHg)

          -  Cerebral surgery &lt; 8 weeks

          -  Major surgery &lt; 4 weeks

          -  Malignancy

          -  Treatment with coumarines

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holger Thiele, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heartcenter Leipzig GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Leipzig - Heart Center</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2006</study_first_submitted>
  <study_first_submitted_qc>August 1, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2006</study_first_posted>
  <last_update_submitted>August 6, 2009</last_update_submitted>
  <last_update_submitted_qc>August 6, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2009</last_update_posted>
  <responsible_party>
    <name_title>University of Leipzig</name_title>
    <organization>Heart Center Leipzig</organization>
  </responsible_party>
  <keyword>infarction</keyword>
  <keyword>facilitated PCI</keyword>
  <keyword>primary PCI</keyword>
  <keyword>infarct size</keyword>
  <keyword>fibrinolysis</keyword>
  <keyword>ST-elevation myocardial infarction (STEMI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

